Astria Therapeutics Inc (ATXS) financials · $382.1M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Astria Therapeutics Inc (ATXS) $382.1M cap.
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Income | -$111.6M | -$83.0M |
| Net Income | -$94.3M | -$72.9M |
| EPS (Diluted) | -$1.68 | -$2.42 |
| Line | FY2024 | FY2023 |
|---|---|---|
| Total Assets | $342.4M | $254.7M |
| Current Assets | $334.6M | $250.9M |
| Cash & Equivalents | $59.8M | $175.5M |
| Total Liabilities | $23.1M | $11.6M |
| Current Liabilities | $19.1M | $11.6M |
| Shareholders' Equity | $319.3M | $243.1M |
| Retained Earnings | -$674.8M | -$580.5M |
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$81.2M | -$68.4M |
| CapEx | $325.0K | $25.0K |
| Investing Cash Flow | -$191.9M | $135.1M |
| Financing Cash Flow | $157.2M | $88.4M |
| Net Change in Cash | -$115.9M | $155.0M |
| Free Cash Flow | -$81.5M | -$68.5M |
FAQ
What is ATXS P/E and revenue?
Astria Therapeutics Inc (ATXS) $382.1M cap.
What is ATXS revenue?
ATXS income-statement cache has no revenue figure yet.
Is ATXS profitable?
Astria Therapeutics Inc last cached net income is -$94.3M (FY2024).
What are ATXS total assets?
Astria Therapeutics Inc last cached total assets are $342.4M (FY2024).
What is ATXS free cash flow?
Astria Therapeutics Inc last cached free cash flow is -$81.5M (FY2024).
Not investment advice. Cached statements, not a live tape.